In a previous study we demonstrated that lncRNA-p21 level is increased after Enzalutamide treatment and promotes NED of PCa through regulating Enhancer of Zeste Homolog 2/signal transducer and activator of transcription 3 signaling (20). This evidence concerns the gene STAT3 and posterior cortical atrophy.